“CLINICAL IMMUNOBIOCHEMICAL MARKERS IN OPTIMIZING THE DIAGNOSTICS OF BRONCHIAL ASTHMA IN COMORBIDITY WITH TYPE 2 DIABETES MELLITUS”. 2025. Modern American Journal of Medical and Health Sciences 1 (8): 51-63. https://usajournals.org/index.php/1/article/view/1362.